2007-July Archives by Author

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...

Starting: Mon Jul 2 11:25:06 2007
Ending: Tue Jul 31 10:37:30 2007
Messages: 98

• [Ip-health] Economist: Drugs firms are rethinking their business model   James ARKINSTALL
• [Ip-health] 3D Vacancy - Programme Coordinator - Intellectual Property and Human Rights   3D -> T HR EE Administration
• [Ip-health] Brazil gets cut-price Aids drug   Tahir Amin
• [Ip-health] 'Sharp drop' in India Aids levels   Tahir Amin
• [Ip-health] Andrew Sullivan: Europe's Beleaguered Drug Companies   Dean Baker
• [Ip-health] Presentation of Indian official to WIPO Patent Colloquium   Thiru Balasubramaniam
• [Ip-health] Dates of WIPO General Assembly: Sept 24, 2007 to October 3, 2007   Thiru Balasubramaniam
• [Ip-health] KEI Policy Blogs: Chile spearheads change at WIPO patent committee   Thiru Balasubramaniam
• [Ip-health] Bridges Weekly: European Parliament Delays Vote on Trips Agreement, Pending New Support for Affordable Drugs   Thiru Balasubramaniam
• [Ip-health] =?WINDOWS-1252?Q?New_York_Times:_Low-Key_Recall_of_AIDS_Drug_Hit?= =?WINDOWS-1252?Q?s_World=92s_Poor?=   Thiru Balasubramaniam
• [Ip-health] IP-Watch: Vacancy Announcement   Thiru Balasubramaniam
• [Ip-health] New York Times: A Patent Is Worth Having, Right? Well, Maybe Not   Thiru Balasubramaniam
• [Ip-health] WHO IGWG: Draft global strategy and plan of action on public health, innovation and intellectual property   Thiru Balasubramaniam
• [Ip-health] Patent board reserves verdict on Novartis plea   Jean Blaylock
• [Ip-health] The New York Times. Re:framing: A Challenge to Gene Theory, a Tougher Look at Biotech   Rosa Castro
• [Ip-health] Europe urged to fund DC generic drugs industry   Michelle Childs
• [Ip-health] UK: PM Brown appoints GSK CEO and Wellcome Trust Chair to new business council   Michelle Childs
• [Ip-health] Abbott cuts price Brazil pays for AIDS drug   Michelle Childs
• [Ip-health] Clinton Foundation subsidizes malaria drugs in Africa   Philip Coticelli
• [Ip-health] Andrew Sullivan: Europe's Beleaguered Drug Companies   Dudley, David D.
• [Ip-health] Andrew Sullivan: Europe's Beleaguered Drug Companies   Dudley, David D.
• [Ip-health] News release: Rwanda first to try buying affordable AIDS drug from Canada using Access to Medicines Regime   Richard Elliott
• [Ip-health] Toronto Star: Rwanda taps Canada for drugs [26 July 2007]   Richard Elliott
• [Ip-health] Bridges Weekly - Rwanda becomes first country to try to use WTO procedure to import patented HIV/AIDS drugs [25 July 2007]   Richard Elliott
• [Ip-health] Rwanda News Agency: Country notifies WTO of plan to import cheap, generic Aids drugs [21 July 2007]   Richard Elliott
• [Ip-health] New Times (Kigali): Country to override copyrights on ARVs [22 July 2007]   Richard Elliott
• [Ip-health] Korea Delay On Pharma FTA   Sean Flynn
• [Ip-health] PUBPAT News: Consumer Groups Support Stem Cell Patent Rejection   Public Patent Foundation
• [Ip-health] PUBPAT News: Key HIV/AIDS Drug Patents To Be Reviewed By U.S. Patent Office   Public Patent Foundation
• [Ip-health] PUBPAT News: Monsanto Patents Asserted Against American Farmers Rejected By Patent Office In PUBPAT Initiated Review   Public Patent Foundation
• [Ip-health] Student Group Helps Ensure Global Access to University Innovations   Caroline Gallant
• [Ip-health] 'Special 301' submissions to USTR   Kathryn Garforth
• [Ip-health] Andrew Sullivan: Europe's Beleaguered Drug Companies   Alec van Gelder
• [Ip-health] New taxes on medicines set to hit hard on poor   Alec van Gelder
• [Ip-health] Guardian Unlimited: NHS doctors challenge high drugs prices   Spring Gombe
• [Ip-health] Socialist Group Press release: Access to medicines for all is Essential for Parliamentary Approval + Press confrerence Strasbourg Wednesday 11th, 14h30   Alexandra HEUMBER
• [Ip-health] European Parliament Questions and Resolution to the Commission and EU Council on Access to medicines TRIPs   Alexandra HEUMBER
• [Ip-health] European Parliament Resolution adopted today on Access to medicines-TRIPs and information related   Alexandra HEUMBER
• [Ip-health] Medicines for poor countries: Socialist MEPs step up the pressure.   Alexandra HEUMBER
• [Ip-health] WTO receives first notification under =?UTF-8?B?4oCYcGFyYWdyYXBoIDbigJkgc3lzdGVt?=   Alexandra HEUMBER
• [Ip-health] MSFon WTO receives first notification under 'paragraph 6' system   Alexandra HEUMBER
• [Ip-health] Dissertation on Access to Medicines and Diagnostics   Brendan Hickey
• [Ip-health] Abbott cuts price Brazil pays for AIDS drug   K.Shadlen@lse.ac.uk
• [Ip-health] Event on the Pipeline mechanism that Brazil has adopted in its legislation affirms the system is unconstitutional   MSF Michel Lotrowska
• [Ip-health] =?iso-8859-1?Q?Brazilian_Minister_of_Health_=28Tempor=E3o=29_says_that_CL?= =?iso-8859-1?Q?_on_Aids_drug_was_a_specific_case..?=   MSF Michel Lotrowska
• [Ip-health] India-Brazil-South Africa Dialogue Forum Ministerial Communique - only points releated to IP-Health and R&D.   MSF Michel Lotrowska
• [Ip-health] JIPLP on Compulsory licencing of Merck Patents in Italy   James Love
• [Ip-health] Text of Rwanda Para.6 submission to TRIPS Council   Suerie Moon
• [Ip-health] Novartis on the Gleevec case in India   Mike Palmedo
• [Ip-health] Korean govt to subsidize local generics to help them cope w/ Korus FTA   Mike Palmedo
• [Ip-health] Profile of Lilly Lobbyist - "Innovation doesn't have to conflict with access to medicines"   Mike Palmedo
• [Ip-health] Lichtenburg study on medical innovation and life expectancy; comparison of US states' life expectancy and their Medicare/Medicaid policies   Mike Palmedo
• [Ip-health] Andrew Sullivan: Europe's Beleaguered Drug Companies   Mike Palmedo
• [Ip-health] AP: Patent Reform Bill on the Move This Week   Mike Palmedo
• [Ip-health] Generic biologics bill in danger - 12 year period of data exclusivity raises concerns   Mike Palmedo
• [Ip-health] WSJ on PhRMA-supported patient group lobbying   Mike Palmedo
• [Ip-health] Penn State Study Urges 'Compensation-Based' Approach to Drug Patent Compulsory Licensing   Mike Palmedo
• [Ip-health] IP Watch on IP Provisions in US Bilateral FTAs   Mike Palmedo
• [Ip-health] Patent board reserves verdict on Novartis plea   Prabhu Ram
• [Ip-health] Do Patents Work?   Prabhu Ram
• [Ip-health] Breast Cancer Action Says Two New Drug Pricing Studies Miss the Mark   Joana Ramos
• [Ip-health] Cancerous Data? Novartis Statistics Whiz Blows The Whistle On Data Reporting System   Joana Ramos
• [Ip-health] Novartis pleads for cancer drug   Joana Ramos
• [Ip-health] Experts tell MPs NICE should slash its maximum QALY price for drug approval   Joana Ramos
• [Ip-health] Govt urged to reconsider CL policy: Glivec 'doesn't need' compulsory licence   Joana Ramos
• [Ip-health] Big Pharma's new Africa plan   Joana Ramos
• [Ip-health] College students pay more for the pill   Joana Ramos
• [Ip-health] A Match for European Tobacco Giants?   Joana Ramos
• [Ip-health] Dying Patients Fight the FDA   Joana Ramos
• [Ip-health] How European Consumers Use the Internet for Health Information   Joana Ramos
• [Ip-health] NIH Public Access Policy Update & what you can do about it now   Manon Ress
• [Ip-health] KEI Letter to US Senate re FY 2008 Labor/HHS Appropriations Bill   Manon Ress
• [Ip-health] Pharmalot: Pharma Must Disclose Charitable, Educational Donations   Sarah Rimmington
• [Ip-health] Arrest of Korean FTA Opponents; protest letter   Ellen Shaffer
• [Ip-health] MSF Symposium on TB field diagnostics: ABSTRACTS + REGISTER NOW!!   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] MSF: New Report Shows Up to 500 Percent Price Rise for AIDS Drugs   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] MSF: Paediatric AIDS Data Show Good Clinical, But Sub-optimal Virological Outcomes   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] Voice of America: New Report Raises Concerns Over Price of New AIDS Drugs   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] DPA, Nation: Thai activists attack drug ban   Sheila.SHETTLE@geneva.msf.org
• [Ip-health] About Abbott's GBC Award   Wim Vandevelde
• [Ip-health] International sign-on: Abbott: Stop the intimidations! We will not be silenced!   Wim Vandevelde
• [Ip-health] IAS Sydney - pre-conference community strategy meeting   Wim Vandevelde
• [Ip-health] RE: Ip-health digest, Vol 1 #2399 - 9 msgs   Wijnberg, dhr. B.
• [Ip-health] Email alert: July issue of the WHO Bulletin   bulletin
• [Ip-health] IGWG DRAFT STRATEGY AND PLAN OF ACTION   charlesclift@tiscali.co.uk
• [Ip-health] WTO receives first notification under ?paragraph 6? system   dshanker@deakin.edu.au
• [Ip-health] Abbott Blockade against Thailand: people with HIV/AIDS invite CEO to crisis resolution meeting   positive generation
• [Ip-health] MONSANTO PATENTS ASSERTED AGAINST AMERICAN FARMERS REJECTED BY PATENT OFFICE   ira
• [Ip-health] Revised text of KORUS FTA   heeseob nam
• [Ip-health] Korea Delay On Pharma FTA   heeseob nam
• [Ip-health] Bruce Sewell op-ed in the Wall Street Journal: Patent Nonsense   thiru@keionline.org
• [Ip-health] Chilean proposal to WIPO Standing Committee on Patents (SCP): L&Es and patents and standards   thiru@keionline.org
• [Ip-health] Comments on Peru/Panama Access to Medicines Provisions   robert weissman
• [Ip-health] Sen Brown/Rep Allen: Respect Doha - Dear Colleague Letter, Re: New Resolution   robert weissman
• [Ip-health] US Senate Res: Respect Doha Declaration and more   robert weissman
• [Ip-health] Sign on: Pharma Should Disclose Organizational Funding   robert weissman
• [Ip-health] BIO's play for perpetual monopoly   robert weissman
• [Ip-health] Health Coalition Calls on Pharma to Disclose Educational and Charitable Funding   robert weissman

Last message date: Tue Jul 31 10:37:30 2007
Archived on: Tue Jul 31 09:37:30 2007

• Messages sorted by: [ thread ] [ subject ] [ date ]
• More info on this list...